AYTU BIOSCIENCE, INC (77) | Stock Agreements (2)
- Restricted Stock Award Agreement between Aytu BioPharma, Inc. and Mark Oki, effective January 17, 2022 (Filed With SEC on February 14, 2022)
- Form of Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock (Filed With SEC on February 7, 2019)
